ICLR vs. PPD, PRAH, IQV, INCY, MEDP, CRL, NRC, OABI, MXCT, and ABSI
Should you be buying ICON Public stock or one of its competitors? The main competitors of ICON Public include PPD (PPD), PRA Health Sciences (PRAH), IQVIA (IQV), Incyte (INCY), Medpace (MEDP), Charles River Laboratories International (CRL), National Research (NRC), OmniAb (OABI), MaxCyte (MXCT), and Absci (ABSI).
ICON Public (NASDAQ:ICLR) and PPD (NASDAQ:PPD) are both large-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, community ranking, media sentiment, earnings, dividends, valuation, institutional ownership, profitability and risk.
ICON Public received 544 more outperform votes than PPD when rated by MarketBeat users. However, 69.74% of users gave PPD an outperform vote while only 65.10% of users gave ICON Public an outperform vote.
In the previous week, ICON Public had 6 more articles in the media than PPD. MarketBeat recorded 14 mentions for ICON Public and 8 mentions for PPD. ICON Public's average media sentiment score of 0.74 beat PPD's score of 0.00 indicating that ICON Public is being referred to more favorably in the media.
95.6% of ICON Public shares are held by institutional investors. Comparatively, 87.8% of PPD shares are held by institutional investors. 44.0% of ICON Public shares are held by insiders. Comparatively, 1.9% of PPD shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
ICON Public has higher revenue and earnings than PPD. ICON Public is trading at a lower price-to-earnings ratio than PPD, indicating that it is currently the more affordable of the two stocks.
ICON Public has a beta of 1.18, suggesting that its share price is 18% more volatile than the S&P 500. Comparatively, PPD has a beta of 1.96, suggesting that its share price is 96% more volatile than the S&P 500.
ICON Public currently has a consensus target price of $342.56, suggesting a potential upside of 5.46%. Given ICON Public's higher probable upside, analysts plainly believe ICON Public is more favorable than PPD.
ICON Public has a net margin of 8.30% compared to PPD's net margin of 6.11%. ICON Public's return on equity of 11.70% beat PPD's return on equity.
Summary
ICON Public beats PPD on 12 of the 17 factors compared between the two stocks.
Get ICON Public News Delivered to You Automatically
Sign up to receive the latest news and ratings for ICLR and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ICLR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
ICON Public Competitors List
Related Companies and Tools
